Skip to main content

Tweets

Full read overview of MDA-5 Dermatomyositis (DM) - pathogenesis, findings, & Rx. MDA-5 DM is a rare, aggressive amyopathic form with distinctive skin findings & rapidly progressive interstitial lung dz. Rx includes Hi dose steroids, calcineurin inhib & IV CTX (maybe JAKi, MMF)

Dr. John Cush @RheumNow ( View Tweet )

6 months 3 weeks ago
AI Advances axSpA Diagnosis with Multimodal MRI Dr. Bella Mehta reports on abstract OP0307 presented at the 2025 EULAR meeting in Barcelona, Spain. https://t.co/fpgwQniSA5 https://t.co/EbT9v821xb
Dr. John Cush @RheumNow ( View Tweet )
6 months 3 weeks ago
Complex-to-Manage PsA: The GRAPPA Framework and Definition Dr. Nelly Ziade discusses abstract OP0175 presented at the EULAR 2025 meeting in Barcelona, Spain. https://t.co/cyDUCGU6Pc https://t.co/jdsTEB3Rqw
Dr. John Cush @RheumNow ( View Tweet )
6 months 3 weeks ago
All Rheumatoid Arthritis is Not the Same Dr. Jonathan Kay reviews abstracts OP0323 and OP0328 from the EULAR 2025 meeting in Barcelona, Spain. https://t.co/rbK3Y1NHVI https://t.co/eYPdbx87kt
Dr. John Cush @RheumNow ( View Tweet )
6 months 3 weeks ago
Assessment of Peripheral Arthritis in Spondyloarthritis Dr. Antoni Chan talks with Dr. Dafne Capelusnik about abstract POS0257 presented at the 2025 EULAR meeting in Barcelona. https://t.co/E6l6qvNnox https://t.co/gLbMjF406q
Dr. John Cush @RheumNow ( View Tweet )
6 months 3 weeks ago
Resilience or Resignation? Rethinking Pain, Aging, and Quality of Life Dr. Jiha Lee reports on abstract POS0402 - THE ROLE OF AGEING IN THE RELATIONSHIP BETWEEN CHRONIC MUSCULOSKELETAL PAIN AND HEALTH-RELATED QUALITY OF LIFE: THE MAASTRICHT STUDY - presented at the 2025 EULAR https://t.co/AiP57hXIRB
Dr. John Cush @RheumNow ( View Tweet )
6 months 3 weeks ago
Remission in Axial Spondyloarthritis Unrelated to Gut Inflammation Most patients with early, active axial spondyloarthritis (axSpA) who quickly received a tumor necrosis factor (TNF) inhibitor experienced remission, and it didn't matter whether or not they had intestinal https://t.co/Sa10k6neRP
Dr. John Cush @RheumNow ( View Tweet )
6 months 3 weeks ago
GRAPPA vs. EULAR on Complex/Difficult-to-Manage Psoriatic Arthritis Following the establishment of formal definitions for Difficult-to-Treat Rheumatoid Arthritis (D2T RA) by EULAR and Difficult-to-Manage axial Spondyloarthritis (D2M axSpA) by ASAS, the “Difficult” framework has https://t.co/NYgivNRgUV
Dr. John Cush @RheumNow ( View Tweet )
6 months 3 weeks ago
Trends and Innovations from Barcelona (6.20.2025) Dr. Jack Cush reviews highlights, trends and novel studies from EULAR 2025 in Barcelona from last week. https://t.co/iEiQI8GACt https://t.co/X27CuZb5wH
Dr. John Cush @RheumNow ( View Tweet )
6 months 3 weeks ago
Simple Measures are Effective in Knee Osteoarthritis Knee braces, water therapy and exercise are the most promising non-drug therapies for treating knee osteoarthritis, according to a new meta-analysis publishing June 18, 2025 in the open-access journal PLOS One by Yuan Luo of https://t.co/4VQpKQJwXu
Dr. John Cush @RheumNow ( View Tweet )
6 months 3 weeks ago
AI in Early Diagnosis of Giant Cell Arteritis Dr. Bella Mehta reviews abstract OP0343 - THE CLAUDICAITIO MODEL: ULTRASOUND IMAGE CLASSIFICATION IN GIANT CELL ARTERITIS BY APPLICATION OF ARTIFICIAL INTELLIGENCE - at the 2025 EULAR meeting in Barcelona. https://t.co/lJFuAgmSTH https://t.co/R1tbYpJ74o
Dr. John Cush @RheumNow ( View Tweet )
6 months 3 weeks ago
Rheumatoid Arthritis Panel: EULAR 2025 Panelists Drs. Mrinalini Dey, Janet Pope, Jonathan Kay and Jack Cush review RA studies and sessions presented at the 2025 EULAR meeting in Barcelona, Spain. Abstracts discussed: OP0004; OP0105; LB0006; OP0327; OP0330; OP0232; 0P0190. https://t.co/hmosUKOgTt
Dr. John Cush @RheumNow ( View Tweet )
6 months 3 weeks ago
×